Philips Healthcare selects Medic Vision's FDA-cleared XR-29 solution for use with its CT and PET/CT scanners

Published on:

TIRAT CARMEL, Israel, Sept. 8, 2016 /PRNewswire/ -- Medic Vision Imaging Solutions, Ltd., the leading innovator of vendor-independent solutions for low-dose CT exams, announced today it was selected by Philips Healthcare to help meet XR-29 regulations.

Following a thorough qualification and verification process, Medic Vision's FDA-cleared SafeCT®-29 product is now officially recommended by Philips as a solution for customers that have CT & PET/CT scanners that are not fully compliant with XR-29 standards and for which Philips does not offer an XR-29 update. Philips tested SafeCT-29, evaluated its FDA 510(k) clearance and determined SafeCT-29 to be safe and effective.

SafeCT-29 is a patent-pending, innovative, add-on system that provides full compliance with the XR-29 Dose Check and Dose Report ("RDSR") functions for CT and PET/CT systems of all vendors and models. It is the only third-party XR-29 solution that is FDA-cleared.  

"We are proud that Philips Healthcare trusts Medic Vision to deliver high-quality dependable solutions at a level consistent with Philips' quality as a leading global healthcare company," said Eyal Aharon, CEO of Medic Vision. "The selection of Medic Vision by Philips validates the quality of the products and services offered by Medic Vision," Aharon said.

According to the agreement between the companies, Philips sales and service personnel will now recommend Medic Vision's SafeCT-29 to Philips customers with XR-29 noncompliant CT and PET/CT scanners. Integration of SafeCT-29 will not affect the Philips warranty, Customer Support Agreement, or its commitment to service the Philips scanners. With that, Philips demonstrates its commitment to help its customers with all scanners and models reaching XR-29 compliance.

For more information on the availability of SafeCT-29, click here.

About Medic Vision  
Medic Vision Imaging Solutions, Ltd. is a leading provider of cost-effective, vendor-independent image enhancement and dose management solutions for CT exams. Medic Vision's FDA-cleared SafeCT® products are in routine clinical use at more than 150 major hospitals and imaging centers nationwide, supporting CT scanners of all vendors and models. The company's SafeCT®product suite provides compliance with the latest regulatory requirements and initiatives related to CT radiation.

 

Related Content

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Radiologists are more accurate, confident when they know the full story
GE HealthCare moves PET/CT scanner production to United States
Use of AI opportunistic screening in CT for cardiovascular disease

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.